Total Equity 13,969 14,054 The Company posted net loss for the second quarter of 2018 amounted to THB 451 million which higher than last year quarter by THB 217 million mainly due to in last year
and all equipment and machinery have been sold out. 4. Trade accounts receivable – related par ties, long past due Unit : million Baht Transactions Company Balance as of 31-12-2018 Balance as of 31-03
current financial assets – Unit trust decreased by 319.5 MB, representing a decrease of 44.4% because in Q1-2022, the Company had sold unit trust in open-end fixed income funds. -4- Trade and other
the Quarter 2’ 2020 6 / 7 Trade and other payables was increased in an amounting of Baht 21.63 million due to expanding credit term of payment and moreover subsidiary company has purchase more
/2561 August 7, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q2/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
-Your-Customer/Customer Due Diligence: KYC/CDD system, causing the company to be fined by the Settlement Committee at the amount of 1,101,000 baht. Moreover, the SEC has suspended approval of two AEC
Company Limited had receive loans from Financial Institution 330.00 Million Baht and company has more temporary investment of 95.17 Million Baht. The trade account and other receivables has decline 86.15
บริษัท ทาคูนิ กรุ๊ป จ ากดั (มหาชน) เลขท่ี 140/1 ถนนกาญจนาภิเษก แขวง/เขตบางแค จังหวัดกรุงเทพฯ 10160 โทร. 02-455-2888 แฟกซ์. 02-455-2763 TAKUNI GROUP PUBLIC COMPANY LIMITED 140/1 KHANJANAPISEK RD
–2018. This is because in Q1–2019, the company had recently purchased products and services of the large–scale project that had not yet been due for payment, resulting in the trade accounts payable